DKK1 and neoplasm: Clinical evaluations across a spectrum of malignancies have detected amplified concentrations of this Wnt antagonist, Dickkopf-1(DKK1), within patient sera and neoplasms, frequently serving as harbingers of an unfavorable prognosis.